Careland Lidocaine Pain Relieving

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Careland Lidocaine Pain Relieving
Generic name
LIDOCAINE
Manufacturer
Planet (Anhui) Pharmaceutical Co., Ltd.
Product type
HUMAN OTC DRUG
SPL set ID
c4c86a8f-1d57-49d2-a65f-acb0dccf2f87
SPL ID
4ffc2188-f2c8-3b21-e063-6294a90a19cf
Version
1
Effective date
2026-04-21
Source export date
2026-09-28
Source partition
8
Source file
https://download.open.fda.gov/drug/label/drug-label-0008-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-09-28/ae3816359e336a5de4f44607730a3d12ceb61ffa012a132189ceda22541b38ee/drug-label-0008-of-0014.json.zip
Source manifest SHA-256
cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run
20260929T050834Z
Imported at
2026-09-29 05:55:28
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

WARNINGS For external use only Do not use more than 1 patch at a time on wounds or damaged skin with a heating pad if you are allergic to any ingredients of this product When using this product use only as directed do not bandage tightly avoid contact with the eyes, mucous membranes or rashes Stop use and ask a doctor if symptoms persist for more than 7 days conditions worsen symptoms clear up and occur again within a few days localized skin reations, such as rash, itching, redness, pain, swelling and blistering develop If pregnant or breast feeding, ask a health professional before use Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.